List of Excipients in API acitretin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acitretin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Stiefel Laboratories Inc | SORIATANE | acitretin | 0145-0090 | CELLULOSE, MICROCRYSTALLINE | |
| Stiefel Laboratories Inc | SORIATANE | acitretin | 0145-0090 | FERRIC OXIDE RED | |
| Stiefel Laboratories Inc | SORIATANE | acitretin | 0145-0090 | FERRIC OXIDE YELLOW | |
| Stiefel Laboratories Inc | SORIATANE | acitretin | 0145-0090 | FERROSOFERRIC OXIDE | |
| Stiefel Laboratories Inc | SORIATANE | acitretin | 0145-0090 | GELATIN | |
| Stiefel Laboratories Inc | SORIATANE | acitretin | 0145-0090 | MALTODEXTRIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing acitretin
Detailed excipient profiles for acitretin
Excipient focus: AMMONIA
acitretin drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing AMMONIA
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acitretin drug variants containing CELLULOSE, MICROCRYSTALLINE
acitretin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
acitretin drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
acitretin drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
acitretin drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: EDETATE DISODIUM
acitretin drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 1
acitretin drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
acitretin drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
acitretin drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
acitretin drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE RED
acitretin drug variants containing FERRIC OXIDE RED
acitretin drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| AvKARE | acitretin | 42291-086 |
| Sigmapharm Laboratories LLC | acitretin | 42794-080 |
| Bryant Ranch Prepack | acitretin | 72162-2222 |
| Bryant Ranch Prepack | acitretin | 72162-2223 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
acitretin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Stiefel Laboratories Inc | acitretin | 0145-0090 |
| AvKARE | acitretin | 42291-086 |
| Sigmapharm Laboratories LLC | acitretin | 42794-080 |
| Alembic Pharmaceuticals Limited | acitretin | 46708-741 |
| Alembic Pharmaceuticals Inc | acitretin | 62332-741 |
| Prasco Laboratories | acitretin | 66993-894 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| Amneal Pharmaceuticals of New York LLC | acitretin | 0115-1667 |
| Amneal Pharmaceuticals of New York LLC | acitretin | 0115-1750 |
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
acitretin drug variants containing FERROSOFERRIC OXIDE
acitretin drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | acitretin | 42291-086 |
| Sigmapharm Laboratories LLC | acitretin | 42794-080 |
| Bryant Ranch Prepack | acitretin | 72162-2222 |
| Bryant Ranch Prepack | acitretin | 72162-2223 |
| Bryant Ranch Prepack | acitretin | 72162-2224 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
acitretin drug variants containing GELATIN
acitretin drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
acitretin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | acitretin | 46708-741 |
| Alembic Pharmaceuticals Inc | acitretin | 62332-741 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
acitretin drug variants containing MALTODEXTRIN
acitretin drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
acitretin drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POLOXAMER 188
acitretin drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing POLOXAMER 188
Excipient focus: POLOXAMER 407
acitretin drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing POLOXAMER 407
Excipient focus: POTASSIUM HYDROXIDE
acitretin drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| Alembic Pharmaceuticals Limited | acitretin | 46708-741 |
| Alembic Pharmaceuticals Inc | acitretin | 62332-741 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
acitretin drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | acitretin | 42291-086 |
| Sigmapharm Laboratories LLC | acitretin | 42794-080 |
| Bryant Ranch Prepack | acitretin | 72162-2222 |
| Bryant Ranch Prepack | acitretin | 72162-2223 |
| Bryant Ranch Prepack | acitretin | 72162-2224 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing POVIDONE
Excipient focus: POVIDONE K90
acitretin drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing POVIDONE K90
Excipient focus: PROPYLENE GLYCOL
acitretin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acitretin | 0093-1135 |
| Amneal Pharmaceuticals of New York LLC | acitretin | 0115-1667 |
| Amneal Pharmaceuticals of New York LLC | acitretin | 0115-1750 |
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Stiefel Laboratories Inc | acitretin | 0145-0090 |
| AvKARE | acitretin | 42291-086 |
| Sigmapharm Laboratories LLC | acitretin | 42794-080 |
| Alembic Pharmaceuticals Limited | acitretin | 46708-741 |
| Alembic Pharmaceuticals Inc | acitretin | 62332-741 |
| Prasco Laboratories | acitretin | 66993-894 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
acitretin drug variants containing SHELLAC
acitretin drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Stiefel Laboratories Inc | acitretin | 0145-0090 |
| AvKARE | acitretin | 42291-086 |
| Sigmapharm Laboratories LLC | acitretin | 42794-080 |
| Prasco Laboratories | acitretin | 66993-894 |
| Bryant Ranch Prepack | acitretin | 72162-2222 |
| Bryant Ranch Prepack | acitretin | 72162-2223 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
acitretin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | acitretin | 46708-741 |
| Alembic Pharmaceuticals Inc | acitretin | 62332-741 |
| >Company | >Ingredient | >NDC |
acitretin drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ASCORBATE
acitretin drug variants containing SODIUM ASCORBATE
acitretin drug variants not containing SODIUM ASCORBATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
acitretin drug variants containing SODIUM LAURYL SULFATE
acitretin drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Stiefel Laboratories Inc | acitretin | 0145-0090 |
| Mylan Pharmaceuticals Inc | acitretin | 0378-7020 |
| Prasco Laboratories | acitretin | 66993-894 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
acitretin drug variants containing TITANIUM DIOXIDE
acitretin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
